WT1 and Wilms tumor: Both the Children’s Oncology Group and other initiatives have elucidated genetic aberrations impacting many pathways crucial for kidney development and oncogenesis, finding that there are recurrent mutations in Wilms tumor of the WT1, CREBBP, and MLLT1 genes [94].